A sodium hyaluronate and a composition thereof
By esterifying all-trans retinoic acid and 13-cis retinoic acid with sodium hyaluronate to form a retinyl hyaluronate sodium derivative, and then forming a complex with polyol compounds, the stability and skin irritation issues of retinoic acid and isotretinoin when used topically are resolved, achieving oil control and acne removal effects, and making it suitable for a variety of topical skin products.
Patent Information
- Application Number
- CN202411907798.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-12-24
- Publication Date
- 2025-11-25
- Estimated Expiration
- 2044-12-24
AI Technical Summary
Retinoic acid and isotretinoin have poor stability when used topically, are highly irritating to the skin, and have limited effects on controlling oil production. The efficacy of existing all-trans retinoic acid (HA) derivatives in the prevention and treatment of acne needs to be improved.
All-trans retinoic acid and 13-cis retinoic acid are simultaneously esterified with sodium hyaluronate to form a retinyl hyaluronate sodium derivative, which is then combined with a polyol compound to form a complex. The grafting rate and ratio of this compound on the skin surface are controlled to form a stable compound.
It improves the stability and antioxidant properties of sodium retinyl hyaluronic acid, significantly inhibits 5α-reductase, has a good oil-control effect, effectively prevents and treats acne, improves the skin's water-oil balance, reduces skin irritation, and is suitable for the preparation of a variety of topical skin products.